TY  - RPRT
TI  - Efficacy of RMC-6236 (Daraxonrasib) and novel combination strategies targeting resistance in RAS pathway-driven neuroblastoma
AU  - Valencia-Sama, I.
AU  - Kee, L.
AU  - Weiss, A.
AU  - Hayes, M.
AU  - Ohh, M.
AU  - Irwin, M.
PY  - 2026
DO  - 10.64898/2026.06.24.734371
UR  - https://www.biorxiv.org/content/10.64898/2026.06.24.734371v1
ID  - 10.64898/2026.06.24.734371
ER  -